Association of alcohol consumption and HIV surrogate markers in participants of the Swiss HIV cohort study

Journal of Acquired Immune Deficiency Syndromes

Volumn 64, Issue 5, 2013, Pages 472-478

  Conen, Anna ^a   Wang, Qing ^b   Glass, Tracy R ^b   Fux, Christoph A ^a   Thurnheer, Maria C ^c   Orasch, Christina ^d   Calmy, Alexandra ^e   Bernasconi, Enos ^f   Vernazza, Pietro ^g   Weber, Rainer ^h   Bucher, Heiner C ^a,i   Battegay, Manuel ⁱ   Fehr, Jan ^h  

^a CANTONAL HOSPITAL AARAU   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^e GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^f REGIONAL HOSPITAL OF LUGANO   (Switzerland)

^g CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^h UNIVERSITY HOSPITAL ZURICH   (Switzerland)

ⁱ UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

alcohol; antiretroviral therapy; CD4 cell count; HIV infection; virological failure

Indexed keywords

ANTIRETROVIRUS AGENT; BIOLOGICAL MARKER;

ADULT; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; DRINKING BEHAVIOR; FEMALE; HIV INFECTIONS; HUMAN; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; SWITZERLAND; VIROLOGY; VIRUS LOAD; ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; STATISTICS;

ADULT; ALCOHOL DRINKING; ANTI-RETROVIRAL AGENTS; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; SWITZERLAND; VIRAL LOAD;

EID: 84892448096     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3182a61ea9     Document Type: Article

References (48)

1. Brundtland GH. From the World Health Organization. Reducing risks to health, promoting healthy life. JAMA. 2002;288:1974
2. WHO. International Guide for Monitoring Alcohol Consumption and Related Harm, Non-communicable Diseases and Health Cluster 2000. Geneva, Switzerland: World Health Organization (WHO).
3. Chander G, Josephs J, Fleishman JA, et al. Alcohol use among HIVinfected persons in care: Results of a multi-site survey. HIV Med. 2008;9: 196-202
4. Samet JH, Cheng DM, Libman H, et al. Alcohol consumption and HIV disease progression. J Acquir Immune Defic Syndr. 2007;46:194-199
5. Galvan FH, Bing EG, Fleishman JA, et al. The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: Results from the HIV Cost and Services Utilization Study. J Stud Alcohol. 2002;63:179-186
6. Cook RL, Sereika SM, Hunt SC, et al. Problem drinking and medication adherence among persons with HIV infection. J Gen Intern Med. 2001; 16:83-88
7. Justice AC, Lasky E, McGinnis KA, et al. Medical disease and alcohol use among veterans with human immunodeficiency infection: A comparison of disease measurement strategies. Med Care. 2006;44(8 suppl 2): S52-S60
8. Lefevre F, O'Leary B, Moran M, et al. Alcohol consumption among HIV-infected patients. J Gen Intern Med. 1995;10:458-460
9. Chander G, Lau B, Moore RD. Hazardous alcohol use: A risk factor for non-adherence and lack of suppression in HIV infection. J Acquir Immune Defic Syndr. 2006;43:411-417
10. Fabris P, Tositti G, Manfrin V, et al. Does alcohol intake affect highly active antiretroviral therapy (HAART) response in HIV-positive patients? J Acquir Immune Defic Syndr. 2000;25:92-93
11. Conen A, Fehr J, Glass TR, et al. Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study. Antivir Ther. 2009;14:349-357
12. Egger M, May M, Chene G, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: A collaborative analysis of prospective studies. Lancet. 2002;360:119-129
13. May MT, Sterne JA, Costagliola D, et al. HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: A collaborative analysis. Lancet. 2006;368: 451-458
14. Ledergerber B, Egger M, Opravil M, et al. Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: A prospective cohort study. Swiss HIV Cohort Study. Lancet. 1999;353:863-868
15. Rosenthal E, Salmon-Ceron D, Lewden C, et al. Liver-related deaths in HIV-infected patients between 1995 and 2005 in the French GERMIVIC Joint Study Group Network (Mortavic 2005 study in collaboration with the Mortalite 2005 survey, ANRS EN19). HIV Med. 2009;10:282-289
16. Bonacini M. Alcohol use among patients with HIV infection. Ann Hepatol. 2011;10:502-507
17. Obel N, Omland LH, Kronborg G, et al. Impact of non-HIV and HIV risk factors on survival in HIV-infected patients on HAART: A populationbased nationwide cohort study. PloS One. 2011;6:e22698
18. Heermans EH. Booze and blood: The effects of acute and chronic alcohol abuse on the hematopoietic system. Clin Lab Sci. 1998;11:229-232
19. Liu X, Zha J, Nishitani J, et al. HIV-1 infection in peripheral blood lymphocytes (PBLs) exposed to alcohol. Virology. 2003;307:37-44
20. Bagasra O, Kajdacsy-Balla A, Lischner HW, et al. Alcohol intake increases human immunodeficiency virus type 1 replication in human peripheral blood mononuclear cells. J Infect Dis. 1993;167:789-797
21. Poonia B, Nelson S, Bagby GJ, et al. Intestinal lymphocyte subsets and turnover are affected by chronic alcohol consumption: Implications for SIV/HIV infection. J Acquir Immune Defic Syndr. 2006;41:537-547
22. Kumar R, Perez-Casanova AE, Tirado G, et al. Increased viral replication in simian immunodeficiency virus/simian-HIV-infected macaques with self-administering model of chronic alcohol consumption. J Acquir Immune Defic Syndr. 2005;39:386-390
23. Bagby GJ, Zhang P, Purcell JE, et al. Chronic binge ethanol consumption accelerates progression of simian immunodeficiency virus disease. Alcohol Clin Exp Res. 2006;30:1781-1790
24. Dingle GA, Oei TP. Is alcohol a cofactor of HIV and AIDS? Evidence from immunological and behavioral studies. Psychol Bull. 1997;122: 56-71
25. Kaslow RA, Blackwelder WC, Ostrow DG, et al. No evidence for a role of alcohol or other psychoactive drugs in accelerating immunodeficiency in HIV-1-positive individuals. A report from the Multicenter AIDS Cohort Study. JAMA. 1989;261:3424-3429
26. Samet JH, Horton NJ, Traphagen ET, et al. Alcohol consumption and HIV disease progression: Are they related? Alcohol Clin Exp Res. 2003; 27:862-867
27. Miguez MJ, Shor-Posner G, Morales G, et al. HIV treatment in drug abusers: Impact of alcohol use. Addict Biol. 2003;8:33-37
28. Ghebremichael M, Paintsil E, Ickovics JR, et al. Longitudinal association of alcohol use with HIV disease progression and psychological health of women with HIV. AIDS Care. 2009;21:834-841
29. Baum MK, Rafie C, Lai S, et al. Alcohol use accelerates HIV disease progression. AIDS Res Hum Retroviruses. 2010;26:511-518
30. Wu ES, Metzger DS, Lynch KG, et al. Association between alcohol use and HIV viral load. J Acquir Immune Defic Syndr. 2011;56:e129-e130
31. Kowalski S, Colantuoni E, Lau B, et al. Alcohol consumption and CD4 T-cell count response among persons initiating antiretroviral therapy. J Acquir Immune Defic Syndromes. 2012;61:455-461
32. Shor-Posner G, Miguez MJ. Heavy alcohol use hinders HIV therapy: Study. AIDS Alert. 2001;16:88-90
33. Samet JH, Horton NJ, Meli S, et al. Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems. Alcohol Clin Exp Res. 2004;28:572-577
34. Schoeni-Affolter F, Ledergerber B, Rickenbach M, et al. Cohort profile: The Swiss HIV Cohort study. Int J Epidemiol. 2010;39:1179-1189
35. Hernan MA, Hernandez-Diaz S, Werler MM, et al. Causal knowledge as a prerequisite for confounding evaluation: An application to birth defects epidemiology. Am J Epidemiol. 2002;155:176-184
36. May M, Wood R, Myer L, et al. CD4(+) T cell count decreases by ethnicity among untreated patients with HIV infection in South Africa and Switzerland. J Infect Dis. 2009;200:1729-1735
37. Boniface S, Shelton N. How is alcohol consumption affected if we account for under-reporting? A hypothetical scenario. Eur J Public Health. 2013. [Epub ahead of print, February 26, 2013. doi: 10.1093/eurpub/ckt016].
38. Glass TR, Battegay M, Cavassini M, et al. Longitudinal analysis of patterns and predictors of changes in self-reported adherence to antiretroviral therapy: Swiss HIV Cohort Study. J Acquir Immune Defic Syndr. 2010;54:197-203
39. Henrich TJ, Lauder N, Desai MM, et al. Association of alcohol abuse and injection drug use with immunologic and virologic responses to HAART in HIV-positive patients from urban community health clinics. J Community Health. 2008;33:69-77
40. Kalichman SC, Grebler T, Amaral CM, et al. Intentional non-adherence to medications among HIV positive alcohol drinkers: Prospective study of Interactive toxicity beliefs. J Gen Intern Med. 2012;28:399-405
41. Hasse B, Ledergerber B, Hirschel B, et al. Frequency and determinants of unprotected sex among HIV-infected persons: The Swiss HIV cohort study. Clin Infec Dis. 2010;51:1314-1322
42. Semple SJ, Strathdee SA, Zians J, et al. Sexual risk behavior associated with co-administration of methamphetamine and other drugs in a sample of HIV-positive men who have sex with men. Am J Addict. 2009;18:65-72
43. Bouhnik AD, Preau M, Lert F, et al. Unsafe sex in regular partnerships among heterosexual persons living with HIV: Evidence from a large representative sample of individuals attending outpatients services in France (ANRS-EN12-VESPA Study). AIDS. 2007;21(suppl 1):S57-S62
44. Bouhnik AD, Preau M, Schiltz MA, et al. Unprotected sex in regular partnerships among homosexual men living with HIV: A comparison between sero-nonconcordant and seroconcordant couples (ANRSEN12- VESPA Study). AIDS. 2007;21(suppl 1):S43-S48
45. Bassetti S, Battegay M, Furrer H, et al. Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort Study. J Acquir Immune Defic Syndr. 1999;21:114-119
46. Kovari H, Sabin CA, Ledergerber B, et al. Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of HBV or HCV co-infection. The data collection on adverse events of anti-HIV drugs (D:A:D) study. Clin Infect Dis. 2012;56:870-879
47. Beer L, Heffelfinger J, Frazier E, et al. Use of and adherence to antiretroviral therapy in a large U.S. sample of HIV-infected adults in care, 2007-2008. Open AIDS J. 2012;6:213-223
48. Braithwaite RS, Bryant KJ. Influence of alcohol consumption on adherence to and toxicity of antiretroviral therapy and survival. Alcohol Res Health. 2010;33:280-287